Table 1.
Characteristic | Study (n = 184) | |
---|---|---|
No. | % | |
Publication year | ||
Before 2012 | 12 | 6.5 |
2013–2016 | 46 | 25.0 |
2017–2020 | 126 | 68.5 |
Study region | ||
North America | 94 | 51.1 |
Europe | 61 | 33.2 |
Asia | 13 | 7.1 |
Others | 4 | 2.2 |
Multiple regions (including more than 1 continent) | 12 | 6.4 |
Study design | ||
Cohort study | 115 | 62.5 |
Case-control study | 12 | 6.5 |
Self-controlled case series | 9 | 4.9 |
Nested case-control study | 7 | 3.8 |
Ecological study | 5 | 2.7 |
Self-controlled cohort study | 2 | 1.1 |
Case-crossover study | 1 | 0.5 |
Cross-sectional study | 1 | 0.5 |
Self-controlled risk interval study | 1 | 0.5 |
Pharmacovigilance study | ||
Disproportionality analysis | 4 | 2.2 |
Sequence symmetry analysis | 3 | 1.6 |
Sequential statistical testing | 3 | 1.6 |
Multiple studies with different designs/methods | 14 | 7.6 |
Reference set identification | 5 | 2.7 |
Others | 2 | 1.1 |
Type of NC | ||
NCE | 54 | 29.3 |
NCO | 91 | 49.5 |
Both NCE and NCO | 34 | 18.5 |
Not applicablea | 5 | 2.7 |
No. of NCs used | ||
Single (either NCE or NCO) | 84 | 45.7 |
Multiple | 94 | 51.0 |
Not applicablea/not reported | 6 | 3.3 |
Type of biasb | ||
Unmeasured confounding | 93 | 50.5 |
Information bias (e.g., misclassification, measurement error) | 10 | 5.4 |
Selection bias | 7 | 3.8 |
Protopathic bias | 2 | 1.1 |
Bias in general/not specified | 80 | 43.5 |
Type of data source usedb | ||
Health-care administrative data (e.g., insurance claims, national health system data) | 114 | 62.0 |
Electronic health records | 61 | 33.2 |
Research data (e.g., primary data) | 26 | 14.1 |
Disease registry | 11 | 6.0 |
Passive surveillance data for drug safety | 7 | 3.8 |
Simulated data set | 6 | 3.3 |
Public health survey data | 4 | 2.2 |
Not applicablea | 5 | 2.7 |
Abbreviations: NC, negative control; NCE, negative control exposure; NCO, negative control outcome.
a Reference set identification studies with no empirical application of NC.
b Categories are not mutually exclusive.